House committee directs FDA to speed up IND sign-off process

June 5, 2026 12:55 PM EDT FDA+ House com­mit­tee di­rects FDA to speed up IND sign-off process Zachary Brennan Senior Editor The House Ap­pro­pri­a­tions Com­mit­tee told the FDA to re­form the way it signs off on new clin­i­cal tri­als, re­flect­ing a broad­er ef­fort to en­sure the … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER